A phase I/II study of cisplatin and radiation in combination with sorafenib in cervical cancer

Trial Profile

A phase I/II study of cisplatin and radiation in combination with sorafenib in cervical cancer

Completed
Phase of Trial: Phase I/II

Latest Information Update: 01 Jan 2016

At a glance

  • Drugs Sorafenib (Primary) ; Cisplatin
  • Indications Cervical cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 29 Jul 2015 Last checked against ClinicalTrials.gov record.
    • 13 Jul 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
    • 06 Oct 2011 Planned end date changed from 1 Jul 2010 to 1 Apr 2012 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top